Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
Wreven E, Ruiz de Adana MS, Hardivillé S, Gmyr V, Kerr-Conte J, Chetboun M, Pasquetti G, Delalleau N, Thévenet J, Coddeville A, Vallejo Herrera MJ, Hinden L, Benavides Espínola IC, Gómez Duro M, Sanchez Salido L, Linares F, Bermúdez-Silva FJ, Tam J, Bonner C, Egan JM, Olveira G, Colomo N, Pattou F, González-Mariscal I.
Wreven E, et al. Among authors: olveira g.
Diabetologia. 2024 Sep;67(9):1877-1896. doi: 10.1007/s00125-024-06193-6. Epub 2024 Jun 12.
Diabetologia. 2024.
PMID: 38864887
Free PMC article.